Apollo Global Management Makes Strategic Minority Investment in vVARDIS Holding AG

April 27, 2026

vVARDIS Holding AG announced a strategic minority investment from funds managed by Apollo Global Management to support the company’s global expansion. The funding is intended to accelerate the commercial rollout of vVARDIS’ non-invasive Curodont peptide-based dental treatment, with a focus on scaling adoption across the United States and Europe.

Targets
vVARDIS Holding AG
Industry
Medical Devices
Location
Switzerland
Transaction Type
Growth capital

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.